Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Khalifa

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
European Urology Oncology|June 11, 2026
Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate CancerQuentin Josset, Audrey Blanc-Lapierre, Grégoire Pigne, et al.
European Urology|August 15, 2025
Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 TrialNicolas Demogeot, Paul Sargos, Julia Salleron, et al.
Neuro-Oncology|July 7, 2023
Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial)Anne Laprie, Georges Noel, Leonor Chaltiel, et al.
BMC Cancer|February 23, 2019
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imagingAnne Laprie, Soléakhéna Ken, Thomas Filleron, et al.
European Urology Oncology|January 23, 2026
Oncological Outcomes of Trimodal Therapy in Primary Versus Secondary Muscle-invasive Bladder Cancer: A Multicenter Retrospective StudyGarvey Mezepo, Zine-Eddine Khene, Jihane Boustani, et al.
Cancers|June 2, 2021
Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown PrimaryYazan Abu-Shama, Julia Salleron, Florent Carsuzaa, et al.
European Journal of Cancer (Oxford, England : 1990)|March 4, 2019
Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort studyCarole Pflumio, Idriss Troussier, Xu Shan Sun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2024
Recommendations for Post-Operative RadioTherapy After Complete Resection of Thymoma-a French DELPHI Consensus InitiativeClémence Basse, Jonathan Khalifa, François Thillays, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
European Urology Oncology|June 11, 2026
Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients with Biochemically Relapsing Prostate CancerQuentin Josset, Audrey Blanc-Lapierre, Grégoire Pigne, et al.
European Urology|August 15, 2025
Short-term Androgen Deprivation Therapy and High-dose Radiotherapy in Intermediate- and High-risk Localized Prostate Cancer: Results from the GETUG 14 Randomized Phase 3 TrialNicolas Demogeot, Paul Sargos, Julia Salleron, et al.
Neuro-Oncology|July 7, 2023
Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial)Anne Laprie, Georges Noel, Leonor Chaltiel, et al.
BMC Cancer|February 23, 2019
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imagingAnne Laprie, Soléakhéna Ken, Thomas Filleron, et al.
European Urology Oncology|January 23, 2026
Oncological Outcomes of Trimodal Therapy in Primary Versus Secondary Muscle-invasive Bladder Cancer: A Multicenter Retrospective StudyGarvey Mezepo, Zine-Eddine Khene, Jihane Boustani, et al.
Cancers|June 2, 2021
Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown PrimaryYazan Abu-Shama, Julia Salleron, Florent Carsuzaa, et al.
European Journal of Cancer (Oxford, England : 1990)|March 4, 2019
Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort studyCarole Pflumio, Idriss Troussier, Xu Shan Sun, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2024
Recommendations for Post-Operative RadioTherapy After Complete Resection of Thymoma-a French DELPHI Consensus InitiativeClémence Basse, Jonathan Khalifa, François Thillays, et al.
Pageof 6